SEC Form 4 · accession 0001209191-19-017534
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas B Neff
Officer — Chief Executive Officer · Director
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 7:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2019 | F | 2,288 | $58.69 | D | 2,627,787 | D | |
| Common StockF1 | Mar 6, 2019 | F | 15,049 | $55.58 | D | 2,612,738 | D | |
| Common Stock | holding | — | — | — | 78,270 | I | By Family Partnership | |
| Common Stock | holding | — | — | — | 20,000 | I | By Spouse | |
| Common StockF2 | holding | — | — | — | 60,946 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
- F2The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.